(Q43778057)

26 November 2017

title

Update of the drug resistance mutations in HIV-1: March 2013 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6148891&resulttype=core&format=json

12 May 2020

5

Deenan Pillay

2 references

26 November 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6148891&resulttype=core&format=json

12 May 2020

3

Huldrych F Gunthard

1 reference

26 November 2017

Victoria A Johnson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6148891&resulttype=core&format=json

12 May 2020

Vincent Calvez

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6148891&resulttype=core&format=json

12 May 2020

Roger Paredes

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6148891&resulttype=core&format=json

12 May 2020

Robert W Shafer

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6148891&resulttype=core&format=json

12 May 2020

Annemarie M Wensing

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6148891&resulttype=core&format=json

12 May 2020

Douglas D Richman

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6148891&resulttype=core&format=json

12 May 2020

Huldrych F Gunthard

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6148891&resulttype=core&format=json

12 May 2020

language of work or name

1 reference

1 February 2013

1 reference

Topics in antiviral medicine

26 November 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6148891&resulttype=core&format=json

12 May 2020

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6148891&resulttype=core&format=json

12 May 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6148891&resulttype=core&format=json

12 May 2020

page(s)

6-14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6148891&resulttype=core&format=json

Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus co-formulated efavirenz, emtricitabine, and tenofovir for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3 trial, analysis of results after 48 weeks

12 May 2020

cites work

1 reference

12 December 2020

Panel of prototypical recombinant infectious molecular clones resistant to nevirapine, efavirenz, etravirine, and rilpivirine

1 reference

12 December 2020

Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate versus ritonavir-boosted atazanavir plus co-formulated emtricitabine and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection: a randomised, d

1 reference

12 December 2020

2011 update of the drug resistance mutations in HIV-1.

1 reference

12 December 2020

Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel.

1 reference

12 December 2020

Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society-USA panel

1 reference

12 December 2020

TMC278, a next-generation nonnucleoside reverse transcriptase inhibitor (NNRTI), active against wild-type and NNRTI-resistant HIV-1.

1 reference

12 December 2020

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6148891&resulttype=core&format=json

12 May 2020

1 reference